Skip to main content
. Author manuscript; available in PMC: 2022 Dec 8.
Published in final edited form as: Neurobiol Aging. 2022 Mar 4;114:15–26. doi: 10.1016/j.neurobiolaging.2022.02.014

Table 1.

Participant characteristics.

All
(n=70)
APOE4 (+)
(n=20)
APOE4 (−)
(n=50)
Age (years) 71±5
[65–87]
71±7
[65–87]
71±5
[65–81]
Workload (W/kg BW) 0.80±.0.27
[0.20–1.46]
0.81±.0.39
[0.20–1.46]
0.80±.0.21
[0.24–1.17]
Gender F=47
M=23
F=13
M=7
F=34
M=16
MMSE 28.6±1.8
[22.0–30.0]
28.6±1.4
[25.0–30.0]
28.7±2.0
[22.0–30.0]
Aβ Deposition 1.09±.17
[0.86 to 1.6]
1.16±.17
[ 0.98 to 1.6]
1.07±.17
[0.86 to 1.6]
CVR 5.55±5.29
[−13.00 to 21.88]
5.18±4.58
[−3.57 to 13.78]
5.69±5.58
[−13.00 to 21.88]
Stroop ratio 0.52±.12
[0.29 to 1.0]
0.51±.12
[0.33 to 0.82]
0.53±.17
[0.29 to 1.00]

MMSE = Mini-Mental State Exam; Aβ = amyloid-beta; CVR = cerebrovascular response to moderate-intensity aerobic exercise; Aβ = amyloid-beta; [Range]; W= Watts at moderate intensity exercise workload; kg BW = kilograms of body weight. Values are depicted as mean ± SD.